We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
Cap. Flow
+$573M
Cap. Flow %
1.31%
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Healthcare 13.05%
3 Financials 12.83%
4 Industrials 10.09%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
3326
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
-189,788
Closed -$8.84M
XLC icon
3327
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
-2,275,000
Closed -$186M
XLF icon
3328
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
-106,220
Closed -$4.47M
XLI icon
3329
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
-67,840
Closed -$8.55M
XLP icon
3330
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
-2,404,644
Closed -$184M
XLU icon
3331
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
-12,400
Closed -$407K
XMTR icon
3332
Xometry
XMTR
$4.79B
-72,153
Closed -$1.22M
XP icon
3333
XP
XP
$8.53B
-2,759,826
Closed -$70.8M
XPER icon
3334
Xperi
XPER
$305M
-17,600
Closed -$212K
XRAY icon
3335
Dentsply Sirona
XRAY
$2.18B
-22,886
Closed -$760K
XRT icon
3336
State Street SPDR S&P Retail ETF
XRT
$491M
-184,610
Closed -$14.6M
XSVM icon
3337
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$659M
-17,700
Closed -$1.01M
XXII
3338
22nd Century Group
XXII
$2.68M
0
-$9.9K
ZJYL
3339
Jin Medical International
ZJYL
$224M
-528
Closed -$40.5K
ZYME icon
3340
Zymeworks
ZYME
$2.05B
-26,430
Closed -$278K
DAY
3341
DELISTED
Dayforce
DAY
-8,300
Closed -$550K
LEGT.U
3342
DELISTED
Legato Merger Corp III Units
LEGT.U
-437,500
Closed -$4.43M
FFLG icon
3343
Fidelity Fundamental Large Cap Growth ETF
FFLG
$611M
-11,400
Closed -$249K
RDDT icon
3344
Reddit
RDDT
$29.5B
-5,000
Closed -$247K
AUNA
3345
Auna
AUNA
$390M
-26,000
Closed -$277K
TRAW icon
3346
Traws Pharma
TRAW
$8.15M
-1,519
Closed -$38.4K
OKLO
3347
Oklo
OKLO
$7.83B
-97,000
Closed -$1.11M
LOGC
3348
DELISTED
ContextLogic
LOGC
-51,062
Closed -$291K
CNR
3349
Core Natural Resources Inc
CNR
$4.72B
-23,347
Closed -$1.96M
ATYR
3350
aTyr Pharma
ATYR
$49.2M
-10,088
Closed -$19.7K

Similar funds

John Overdeck's Q2 2024 Portfolio in Review

As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
  • John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
  • John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
  • John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
  • John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
  • John Overdeck opened 479 new positions and closed 480 in Q2 2024.
  • John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.